Table of Contents
PPT Slide
PPT Slide
Methamphetamine: New Knowledge, New Treatments.
Methamphetamine.Speed in Sweden
Methamphetamine.A Previous U.S. Epidemic
PPT Slide
PPT Slide
ADAM Methamphetamine Data by Site.(male arrestees -- selected cities)
ADAM Methamphetamine Data by Site.(male arrestees -- selected cities)
ADAM Methamphetamine Data by Site.(male arrestees -- selected cities)
ADAM Methamphetamine Data by Site.(male arrestees -- selected cities)
Toxic Effects .of Methamphetamine
Toxic Effects of .Methamphetamine Manufacturing
Toxic Effects of .Methamphetamine Manufacturing
PPT Slide
Toxic Effects of .Methamphetamine Manufacturing
PPT Slide
Toxic Effects of .Methamphetamine Manufacturing
Organ Toxicity from MA Abuse
CNS Toxicity from MA Abuse
Cardiovascular Toxicity.from MA Abuse
Pulmonary Toxicity.from MA Abuse
Renal / Hepatic Toxicity .from MA Abuse
Fetal Toxicity from MA Abuse
PPT Slide
SUMMARY
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
Cognitive Impairment in Individuals Currently Using Methamphetamine
Acknowledgements
Memory Difference between Stimulant and Comparison Groups
Differences between Stimulant and Comparison Groups on Tests Requiring Perceptual Speed
Summary
Longitudinal Memory Performance
Longitudinal Memory Summary
Summary (cont.)
Methamphetamine: .User Characterstics and Treatment Response
Methamphetamine.Acute Physical Effects
Methamphetamine.Acute Psychological Effects
PPT Slide
Methamphetamine.Chronic Physical Effects
Methamphetamine.Chronic Psychological Effects
Methamphetamine.Psychiatric Consequences
Typical Day of MA Use
Typical Day of MA Use
Project Overview
PPT Slide
Participant Characteristics
Participant Characteristics
Drug Use Information
Other Substance Use
Alcohol Use
Alcohol Use
Drug Use Information
Self-Reported Medical Problems
Self-Reported Psych Problems
Comparisons of IV/non-IV Users
Comparisons of IV/non-IV Users
Treatment: Matrix Model
Treatment Services Received.(hours received)
Urinalysis Results
Treatment Retention
MA - Cocaine.Follow-up Comparison
MA - Cocaine.Follow-up Comparison
MA - Cocaine.Follow-up Comparison
Follow-up of 114 MA Users Treated with Matrix Model
Follow-up of 114 MA Users Treated with Matrix Model
Follow-up of 114 MA Users Treated with Matrix Model
Follow-up of 114 MA Users Treated with Matrix Model
Psychoactive Substance Use.and Sexual Behavior:.A Survey and Analysis
Project Description
Participant Characteristics
Substance Use.(All Subjects; N=437)
Primary MA Users.Demographics (N=55)
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
Psychoactive Substances and Sexual Behaviors
MA Treatment Issues
Acute MA Overdose
Acute MA Psychosis
Treatment of MA Psychosis
MA “Withdrawal”
Treatment of MA “Withdrawal”
Treatment of MA “Withdrawal”
Initiating MA Abstinence
Initiating MA Abstinence
Treatment of MA Disorders
Treatment of MA Disorders
Stimulant Treatment Issues
Matrix Model of Stimulant .Abuse Treatment
Matrix Model of Stimulant .Abuse Treatment
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
Stimulant Recovery Issues
|